| Symptoms (n=17) | CXR (n=39) | CT (n=13) |
---|---|---|---|
Stage IA (n = 25) | 4 (23.5%) | 13 (33.3%) | 8 (61.5%)a |
Stage IB (n = 8) | 1 (5.9%) | 6 (15.4%) | 1 (7.7%) |
Stage IIA (n = 13) | 3 (17.6%) | 8 (20.5%) | 2 (15.4%) |
Stage IIB (n = 5) | 1 (5.9%) | 4 (10.3%) | 0 |
Stage IIIA (n = 11) | 3 (17.6%) | 8 (15.4%) | 0 |
Stage IIIB (n = 7) | 5 (29.4%) | 0 | 2 (15.4%) |